|
|
Volumn 17, Issue 7, 2002, Pages 1676-1680
|
|
Is there a risk of prion disease after the administration of urinary-derived gonadotrophins?
|
|
Author keywords
BSE; Prion disease; Recombinant gonadotrophins; Urinary gonadotrophins; Variant CJD
|
|
Indexed keywords
CHORIONIC GONADOTROPIN;
GROWTH HORMONE;
HUMAN MENOPAUSAL GONADOTROPIN;
PRION PROTEIN;
RECOMBINANT CHORIONIC GONADOTROPIN;
RECOMBINANT FOLLITROPIN;
UROFOLLITROPIN;
BLOOD TRANSFUSION;
BOVINE SPONGIFORM ENCEPHALOPATHY;
CELL CULTURE;
COST BENEFIT ANALYSIS;
CREUTZFELDT JAKOB DISEASE;
CULTURE MEDIUM;
DIAGNOSTIC TEST;
DISEASE CLASSIFICATION;
DISEASE PREDISPOSITION;
DISEASE TRANSMISSION;
DRUG EFFICACY;
DRUG MANUFACTURE;
DRUG SAFETY;
DRUG SYNTHESIS;
DRUG WITHDRAWAL;
FETAL CALF SERUM;
FOOD CONTAMINATION;
FOOD INTAKE;
GENE MUTATION;
GENETIC SUSCEPTIBILITY;
HETEROZYGOTE DETECTION;
HUMAN;
INFECTION RISK;
INOCULATION;
LIVESTOCK;
NONHUMAN;
POSTMENOPAUSE;
PRESCRIPTION;
PRION DISEASE;
PROTEIN PURIFICATION;
PROTEIN URINE LEVEL;
REVIEW;
RISK ASSESSMENT;
SCRAPIE;
URINALYSIS;
ANIMALIA;
BOVINAE;
|
|
EID: 0036070010
PISSN: 02681161
EISSN: None
Source Type: Journal
DOI: 10.1093/humrep/17.7.1676-a Document Type: Review |
|
Times cited : (21)
|
|
References (21)
|
